Sun, Jun 21, 2026
Hamidreza Kalantari * 
, Mehri Habibi , Atosa Ferdousi , Mohammad Reza Asadi Karam , Taher Mohammadian
, Mehri Habibi , Atosa Ferdousi , Mohammad Reza Asadi Karam , Taher Mohammadian
Department of Microbiology, ShQ.C., Islamic Azad University, Shahr-e Qods, Iran.
Abstract: (13 Views)
Introduction: Pseudomonas aeruginosa is a major opportunistic pathogen causing urinary tract infections (UTIs), particularly in hospitalized or immunocompromised patients. Rising antibiotic resistance highlights the urgent need for effective vaccines. PcrV and OmpE as key virulence factors of P. aeruginosa are promising targets for vaccine development. In a previous study, a multi-epitope vaccine construct consisting B- and T-cell epitopes of PcrV and OmpE from P. aeruginosa was designed using immunoinformatics tools. In the present study, the immunogenicity of the recombinant protein was assessed in a murine model.
Methods: After purification of the multi-epitope protein PcrV.OmpE using Nickel resin, different vaccine formulations including multi-epitope protein alone and admixed with alum were injected into mice through the subcutaneous route. Thereafter, the levels of systemic humoral and mucosal immune responses were investigated using ELISA method.
Results: The multi-epitope vaccine construct alone elicited strong systemic IgG and IgA responses, as well as mucosal antibody in urine as compared to the control mice (p<0.05). The addition of alum significantly boosted systemic IgG and IgA, as well as mucosal IgG antibody response as compared to the multi-epitope alone (p<0.05).
Conclusion: These results support the potential of a multi-epitope composed of PcrV and OmpE antigens for the prevention of P. aeruginosa-associated UTIs, warranting further studies on cellular immunity and protective efficacy.
Methods: After purification of the multi-epitope protein PcrV.OmpE using Nickel resin, different vaccine formulations including multi-epitope protein alone and admixed with alum were injected into mice through the subcutaneous route. Thereafter, the levels of systemic humoral and mucosal immune responses were investigated using ELISA method.
Results: The multi-epitope vaccine construct alone elicited strong systemic IgG and IgA responses, as well as mucosal antibody in urine as compared to the control mice (p<0.05). The addition of alum significantly boosted systemic IgG and IgA, as well as mucosal IgG antibody response as compared to the multi-epitope alone (p<0.05).
Conclusion: These results support the potential of a multi-epitope composed of PcrV and OmpE antigens for the prevention of P. aeruginosa-associated UTIs, warranting further studies on cellular immunity and protective efficacy.
Type of Study: Research |
Subject:
Vaccine development, efficacy and safety evaluation
Received: 2026/06/21
Received: 2026/06/21
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.